SCHEMBL8666071

SCHEMBL8666071

CCCCCS(=O)(=O)c1ccc([N+](=O)[O-])c(C(=O)O)c1

nearest known ligand 0.49

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
TXNRD1 Q16881 4/20 0.49
GSR P00390 1/20 0.49
DTYMK P23919 1/20 0.47
VCAM1 P19320 2/20 0.46
THRB P10828 3/20 0.45
S1PR3 Q99500 1/20 0.44
HCAR3 P49019 2/20 0.43
THRA P10827 1/20 0.41
GAA P10253 1/20 0.41
MAPT P10636 1/20 0.41
CA2 P00918 1/20 0.40
AKR1C3 P42330 1/20 0.40
AKR1C2 P52895 1/20 0.40
AKR1C1 Q04828 1/20 0.40
POLB P06746 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9658492 0.83 DTYMK (0.51) DTYMKVCAM1GAACA2POLB
SCHEMBL11311354 0.83 S1PR3 (0.45) TXNRD1GSRVCAM1THRBS1PR3
SCHEMBL10347259 0.80 KAT8 (0.61) THRBS1PR3THRACA2
SCHEMBL1129732 0.80 KAT8 (0.61) THRBS1PR3THRACA2
SCHEMBL8962184 0.79 THRB (0.48) THRBS1PR3THRACA2POLB
SCHEMBL11440376 0.79 S1PR3 (0.42) TXNRD1GSRTHRBS1PR3THRA
SCHEMBL11158183 0.78 KAT8 (0.55) DTYMKHCAR3GAAMAPTAKR1C2
SCHEMBL11439912 0.78 THRB (0.50) TXNRD1GSRVCAM1THRB
SCHEMBL20503359 0.77 RARB (0.56) THRBS1PR3THRA
SCHEMBL10673351 0.77 PPARA (0.61) THRBS1PR3THRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5726305-A Substituted quinoline-2-carboxamides, their preparation and their use as pharmaceuticals, and intermediates HOECHST AKTIENGESELLSCHAFT (DE) 1998-03-10 US disclosed
US-5719164-A Substituted quinoline-2-carboxamides, their preparation and their use as pharmaceuticals, and intermediates HOECHST AKTIENGESELLSCHAFT (DE) 1998-02-17 US disclosed